Your browser doesn't support javascript.
loading
Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML.
Schütz, C; Inselmann, S; Saussele, S; Dietz, C T; Mu Ller, M C; Eigendorff, E; Brendel, C A; Metzelder, S K; Bru Mmendorf, T H; Waller, C; Dengler, J; Goebeler, M E; Herbst, R; Freunek, G; Hanzel, S; Illmer, T; Wang, Y; Lange, T; Finkernagel, F; Hehlmann, R; Huber, M; Neubauer, A; Hochhaus, A; Guilhot, J; Xavier Mahon, F; Pfirrmann, M; Burchert, A.
Afiliação
  • Schütz C; Department of Hematology, Oncology and Immunology, University Hospital Marburg, Marburg, Germany.
  • Inselmann S; Department of Hematology, Oncology and Immunology, University Hospital Marburg, Marburg, Germany.
  • Saussele S; III. Medizinische Klinik, Medizinische Fakultät Mannheim, University Heidelberg, Mannheim, Germany.
  • Dietz CT; III. Medizinische Klinik, Medizinische Fakultät Mannheim, University Heidelberg, Mannheim, Germany.
  • Mu Ller MC; III. Medizinische Klinik, Medizinische Fakultät Mannheim, University Heidelberg, Mannheim, Germany.
  • Eigendorff E; Department of Hematology and Oncology, University Hospital Jena, Jena, Germany.
  • Brendel CA; Department of Hematology, Oncology and Immunology, University Hospital Marburg, Marburg, Germany.
  • Metzelder SK; Department of Hematology, Oncology and Immunology, University Hospital Marburg, Marburg, Germany.
  • Bru Mmendorf TH; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, RWTH Aachen University Hospital, Aachen, Germany.
  • Waller C; Department of Hematology and Oncology, University Hospital Freiburg.
  • Dengler J; Onkologische Praxis Heilbronn, Heilbronn, Germany.
  • Goebeler ME; Department of Hematology and Oncology, University Hospital Würzburg, Würzburg, Germany.
  • Herbst R; Department of Hematology/Oncology, Klinikum Chemnitz, Chemnitz, Germany.
  • Freunek G; MVZ Klinikum Straubing GmbH, Straubing, Germany.
  • Hanzel S; Klinikum Kempten-Oberallgäu GmbH, Kempten, Germany.
  • Illmer T; BAG Freiberg-Richter, Jacobasch, Wolf, Illmer, Dresden, Germany.
  • Wang Y; Department of Hematology, Oncology and Immunology, University Hospital Marburg, Marburg, Germany.
  • Lange T; Asklepios Klinikum Weißenfels, Weißenfels, Germany.
  • Finkernagel F; Center for Tumor and Immunbiology, University Marburg, Marburg, Germany.
  • Hehlmann R; III. Medizinische Klinik, Medizinische Fakultät Mannheim, University Heidelberg, Mannheim, Germany.
  • Huber M; Institute for Medical Microbiology and Hospital Hygiene, University of Marburg, Biomedical Research Center (BMFZ), Marburg, Germany.
  • Neubauer A; Department of Hematology, Oncology and Immunology, University Hospital Marburg, Marburg, Germany.
  • Hochhaus A; Department of Hematology and Oncology, University Hospital Jena, Jena, Germany.
  • Guilhot J; Clinical Investigation Center, Poitiers, France.
  • Xavier Mahon F; Hematology Laboratory, CHU Bordeaux, Bordeaux, France.
  • Pfirrmann M; Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie, Ludwig-Maximilians-Universität München, Munich, Germany.
  • Burchert A; Department of Hematology, Oncology and Immunology, University Hospital Marburg, Marburg, Germany.
Leukemia ; 31(4): 829-836, 2017 04.
Article em En | MEDLINE | ID: mdl-28074067
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Células Dendríticas / Leucemia Mielogênica Crônica BCR-ABL Positiva / Antígeno B7-2 / Antígeno CTLA-4 Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Células Dendríticas / Leucemia Mielogênica Crônica BCR-ABL Positiva / Antígeno B7-2 / Antígeno CTLA-4 Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Alemanha